Physician profile
Allison A Przekop
NPI 1740493717
$5,865.79
in general payments reported to CMS, 2019-2025
8 companies · $4,955 in 2025
The $4,955 reported for 2025 was more than what 86% of Neurology With Special Qualifications In Child Neurology providers received nationally (typical 2025 total: $275).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $0.83 · 2020: $24.05 · 2022: $208 · 2023: $572 · 2024: $106 · 2025: $4,955.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,565 · Food and Beverage: $842 · Travel and Lodging: $226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,565.00 |
| Food and Beverage | $841.95 |
| Travel and Lodging | $226.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $4,684.71 | 2023-2025 | Daybue |
| Ipsen Biopharmaceuticals, INC | $444.18 | 2020-2025 | Dysport |
| Medtronic, INC. | $353.98 | 2022-2025 | Percept PC Brainsense, Activa PC |
| Boston Scientific Corporation | $212.11 | 2023 | Vercise |
| Insightec,INC | $113.05 | 2022 | |
| Abbvie INC. | $54.44 | 2023 | |
| Travere Therapeutics, INC. | $3.32 | 2019-2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Przekop listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.